NASDAQ:TRHC - Tabula Rasa HealthCare Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$52.23 -0.77 (-1.45 %)
(As of 05/25/2018 04:00 PM ET)
Previous Close$52.23
Today's Range$52.02 - $54.02
52-Week Range$12.63 - $54.02
Volume167,634 shs
Average Volume277,393 shs
Market Capitalization$1.06 billion
P/E Ratio-1,305.75
Dividend YieldN/A
Beta2.38

About Tabula Rasa HealthCare (NASDAQ:TRHC)

Tabula Rasa HealthCare logoTabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

Receive TRHC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRHC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:TRHC
CUSIPN/A
Phone866-648-2767

Debt

Debt-to-Equity Ratio0.01
Current Ratio0.45
Quick Ratio0.41

Price-To-Earnings

Trailing P/E Ratio-1,305.75
Forward P/E Ratio116.07
P/E Growth4.73

Sales & Book Value

Annual Sales$134.55 million
Price / Sales7.77
Cash Flow$0.4925 per share
Price / Cash106.04
Book Value$5.29 per share
Price / Book9.87

Profitability

EPS (Most Recent Fiscal Year)($0.04)
Net Income$14.29 million
Net Margins-0.61%
Return on Equity0.38%
Return on Assets0.22%

Miscellaneous

Employees536
Outstanding Shares20,010,000

Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare (NASDAQ:TRHC) announced its quarterly earnings data on Tuesday, May, 8th. The company reported $0.10 EPS for the quarter, topping the Zacks' consensus estimate of $0.01 by $0.10. The firm earned $43.94 million during the quarter, compared to analyst estimates of $42.60 million. Tabula Rasa HealthCare had a positive return on equity of 0.38% and a negative net margin of 0.61%. The business's quarterly revenue was up 57.0% compared to the same quarter last year. During the same period last year, the company posted $0.08 EPS. View Tabula Rasa HealthCare's Earnings History.

When is Tabula Rasa HealthCare's next earnings date?

Tabula Rasa HealthCare is scheduled to release their next quarterly earnings announcement on Monday, August, 6th 2018. View Earnings Estimates for Tabula Rasa HealthCare.

What price target have analysts set for TRHC?

12 equities research analysts have issued 12-month price objectives for Tabula Rasa HealthCare's shares. Their predictions range from $16.00 to $68.00. On average, they expect Tabula Rasa HealthCare's stock price to reach $42.4545 in the next year. View Analyst Ratings for Tabula Rasa HealthCare.

Who are some of Tabula Rasa HealthCare's key competitors?

Who are Tabula Rasa HealthCare's key executives?

Tabula Rasa HealthCare's management team includes the folowing people:
  • Dr. Calvin H. Knowlton, Co-Founder, Chairman & CEO (Age 68)
  • Dr. Orsula V. Knowlton BScPharm, PharmD, MBA, Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director (Age 49)
  • Mr. Brian W. Adams, CFO & Sec. (Age 36)
  • Mr. Michael Greenhalgh BScPharm, RPh, Chief Operating Officer
  • Ms. Andrea Carolan Speers, Corp. Controller & Chief Accounting Officer (Age 37)

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers.

Has Tabula Rasa HealthCare been receiving favorable news coverage?

Media headlines about TRHC stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Tabula Rasa HealthCare earned a media sentiment score of 0.12 on Accern's scale. They also assigned news articles about the company an impact score of 46.80 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.17%), Hood River Capital Management LLC (4.47%), Allianz Asset Management GmbH (1.03%), Allianz Asset Management GmbH (1.03%), Wasatch Advisors Inc. (0.92%) and Pier Capital LLC (0.76%). Company insiders that own Tabula Rasa HealthCare stock include Brian W Adams, Bruce Luehrs, Calvin H Knowlton, Glen R Bressner, Gordon Tunstall, Growth Fund 1Q Lp Originate, Joann M Durham and Orsula V Knowlton. View Institutional Ownership Trends for Tabula Rasa HealthCare.

Which major investors are selling Tabula Rasa HealthCare stock?

TRHC stock was sold by a variety of institutional investors in the last quarter, including Pier Capital LLC, Granite Investment Partners LLC, Wasatch Advisors Inc., Citadel Advisors LLC, California Public Employees Retirement System and Next Century Growth Investors LLC. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Bruce Luehrs, Calvin H Knowlton, Gordon Tunstall, Growth Fund 1Q Lp Originate and Orsula V Knowlton. View Insider Buying and Selling for Tabula Rasa HealthCare.

Which major investors are buying Tabula Rasa HealthCare stock?

TRHC stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Braun Stacey Associates Inc., Principal Financial Group Inc., Principal Financial Group Inc., Intrinsic Edge Capital Management LLC, Osterweis Capital Management Inc., Tygh Capital Management Inc. and Bamco Inc. NY. Company insiders that have bought Tabula Rasa HealthCare stock in the last two years include Brian W Adams and Glen R Bressner. View Insider Buying and Selling for Tabula Rasa HealthCare.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $52.23.

How big of a company is Tabula Rasa HealthCare?

Tabula Rasa HealthCare has a market capitalization of $1.06 billion and generates $134.55 million in revenue each year. The company earns $14.29 million in net income (profit) each year or ($0.04) on an earnings per share basis. Tabula Rasa HealthCare employs 536 workers across the globe.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]


MarketBeat Community Rating for Tabula Rasa HealthCare (TRHC)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  123 (Vote Outperform)
Underperform Votes:  106 (Vote Underperform)
Total Votes:  229
MarketBeat's community ratings are surveys of what our community members think about Tabula Rasa HealthCare and other stocks. Vote "Outperform" if you believe TRHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRHC will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Tabula Rasa HealthCare (NASDAQ:TRHC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
12 Wall Street analysts have issued ratings and price targets for Tabula Rasa HealthCare in the last 12 months. Their average twelve-month price target is $42.4545, suggesting that the stock has a possible downside of 18.72%. The high price target for TRHC is $68.00 and the low price target for TRHC is $16.00. There are currently 1 hold rating and 11 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.922.912.902.86
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $42.4545$36.2222$28.75$27.8571
Price Target Upside: 18.72% downside7.74% upside1.47% downside1.43% downside

Tabula Rasa HealthCare (NASDAQ:TRHC) Consensus Price Target History

Price Target History for Tabula Rasa HealthCare (NASDAQ:TRHC)

Tabula Rasa HealthCare (NASDAQ:TRHC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/21/2018MEDBoost Price TargetOutperform$47.00 ➝ $63.00MediumView Rating Details
5/18/2018Chardan CapitalBoost Price TargetBuy$50.00 ➝ $68.00LowView Rating Details
5/9/2018CitigroupReiterated RatingBuy$57.00HighView Rating Details
5/9/2018Piper Jaffray CompaniesReiterated RatingOverweight$46.00HighView Rating Details
3/13/2018CIBCReiterated RatingOutperform ➝ Outperform$35.00 ➝ $47.00MediumView Rating Details
3/13/2018OppenheimerBoost Price TargetOutperform$35.00 ➝ $47.00HighView Rating Details
3/13/2018William BlairReiterated RatingOutperformHighView Rating Details
11/1/2017First AnalysisInitiated CoverageOverweight$41.00N/AView Rating Details
10/19/2017Wells Fargo & CoBoost Price TargetMarket Perform$21.00 ➝ $27.00N/AView Rating Details
10/17/2017Robert W. BairdReiterated RatingOutperform$22.00 ➝ $30.00N/AView Rating Details
8/30/2017UBSBoost Price TargetBuy ➝ Buy$18.00 ➝ $25.00MediumView Rating Details
7/14/2017Stifel NicolausReiterated RatingBuy$16.00LowView Rating Details
(Data available from 5/26/2016 forward)

Earnings

Tabula Rasa HealthCare (NASDAQ:TRHC) Earnings History and Estimates Chart

Earnings by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Tabula Rasa HealthCare (NASDAQ:TRHC) Earnings Estimates

2018 EPS Consensus Estimate: $0.26
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.08)($0.06)($0.07)
Q2 20182$0.01$0.11$0.06
Q3 20183($0.03)$0.24$0.12
Q4 20182$0.01$0.29$0.15

Tabula Rasa HealthCare (NASDAQ TRHC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/6/2018        
5/8/2018Q1 2018$0.0050$0.10$42.60 million$43.94 millionViewN/AView Earnings Details
3/12/2018Q4 2017$0.12$0.09$38.91 million$43.93 millionViewN/AView Earnings Details
11/6/2017Q3 2017$0.06$0.08$31.76 million$33.27 millionViewN/AView Earnings Details
8/7/2017Q2 2017$0.06$0.06$27.84 million$29.70 millionViewListenView Earnings Details
5/1/2017Q1 2017$0.06$0.04$26.00 million$27.70 millionViewListenView Earnings Details
3/13/2017Q4 2016$0.11$0.10$25.53 million$27.30 millionViewN/AView Earnings Details
11/9/2016Q316$0.03$0.06$22.35 million$24.17 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Tabula Rasa HealthCare (NASDAQ:TRHC) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Tabula Rasa HealthCare (NASDAQ TRHC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 14.00%
Institutional Ownership Percentage: 63.09%
Insider Trading History for Tabula Rasa HealthCare (NASDAQ:TRHC)
Institutional Ownership by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Tabula Rasa HealthCare (NASDAQ TRHC) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/22/2018Bruce LuehrsDirectorSell85,842$50.66$4,348,755.72View SEC Filing  
5/17/2018Bruce LuehrsDirectorSell32,431$49.16$1,594,307.96View SEC Filing  
5/17/2018Orsula V KnowltonPresidentSell8,000$50.19$401,520.00View SEC Filing  
5/15/2018Bruce LuehrsDirectorSell67,569$47.99$3,242,636.31View SEC Filing  
5/7/2018Orsula V KnowltonPresidentSell8,000$42.79$342,320.00View SEC Filing  
4/9/2018Calvin H KnowltonCEOSell8,000$38.69$309,520.00View SEC Filing  
3/20/2018Bruce LuehrsDirectorSell12,234$38.01$465,014.34View SEC Filing  
3/13/2018Bruce LuehrsDirectorSell16,745$37.63$630,114.35View SEC Filing  
3/9/2018Bruce LuehrsDirectorSell15,664$37.09$580,977.76View SEC Filing  
3/7/2018Calvin H KnowltonCEOSell8,000$35.59$284,720.00View SEC Filing  
3/6/2018Bruce LuehrsDirectorSell3,115$36.03$112,233.45View SEC Filing  
2/22/2018Bruce LuehrsDirectorSell252,242$34.29$8,649,378.18View SEC Filing  
2/7/2018Calvin H KnowltonCEOSell8,000$34.75$278,000.00View SEC Filing  
1/12/2018Brian W AdamsCFOBuy5,391$14.23$76,713.93View SEC Filing  
1/8/2018Calvin H KnowltonCEOSell8,000$32.75$262,000.00View SEC Filing  
12/11/2017Bruce LuehrsDirectorSell269,000$25.85$6,953,650.00View SEC Filing  
12/11/2017Growth Fund 1Q Lp OriginateMajor ShareholderSell684,180$25.85$17,686,053.00View SEC Filing  
12/8/2017Gordon TunstallDirectorSell15,000$25.85$387,750.00View SEC Filing  
12/8/2017Orsula V KnowltonInsiderSell123,000$25.97$3,194,310.00View SEC Filing  
10/18/2017Orsula V KnowltonInsiderSell8,000$26.68$213,440.00View SEC Filing  
9/13/2017Orsula V KnowltonInsiderSell8,000$22.10$176,800.00887,407View SEC Filing  
8/16/2017Calvin H KnowltonCEOSell8,000$17.21$137,680.00918,362View SEC Filing  
7/19/2017Orsula V KnowltonInsiderSell8,000$14.20$113,600.00903,407View SEC Filing  
6/14/2017Orsula V. KnowltonInsiderSell8,000$14.02$112,160.00View SEC Filing  
6/12/2017Gordon TunstallDirectorSell22,759$13.76$313,163.845,565View SEC Filing  
5/18/2017Glen R BressnerDirectorBuy7,500$11.96$89,700.0018,256View SEC Filing  
5/17/2017Orsula V KnowltonInsiderSell8,000$11.94$95,520.00919,407View SEC Filing  
10/4/2016Glen R BressnerDirectorBuy8,500$12.00$102,000.002,793,932View SEC Filing  
10/4/2016Joann M DurhamMajor ShareholderSell4,070$12.00$48,840.0012,886View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Tabula Rasa HealthCare (NASDAQ TRHC) News Headlines

Source:
DateHeadline
Tabula Rasa HealthCare President and Co-Founder Named A Fellow of the College of Physicians of PhiladelphiaTabula Rasa HealthCare President and Co-Founder Named A Fellow of the College of Physicians of Philadelphia
finance.yahoo.com - May 25 at 4:44 PM
Tabula Rasa HealthCare President and Co-Founder Named A Fellow of the College of Physicians of PhiladelphiaTabula Rasa HealthCare President and Co-Founder Named A Fellow of the College of Physicians of Philadelphia
finance.yahoo.com - May 25 at 4:44 PM
Insider Selling: Tabula Rasa HealthCare (TRHC) Director Sells 85,842 Shares of StockInsider Selling: Tabula Rasa HealthCare (TRHC) Director Sells 85,842 Shares of Stock
www.americanbankingnews.com - May 22 at 7:10 PM
Tabula Rasa HealthCare (TRHC) Given "Outperform" Rating at MEDTabula Rasa HealthCare (TRHC) Given "Outperform" Rating at MED
www.americanbankingnews.com - May 21 at 10:54 AM
Tabula Rasa HealthCare (TRHC) President Orsula V. Knowlton Sells 8,000 SharesTabula Rasa HealthCare (TRHC) President Orsula V. Knowlton Sells 8,000 Shares
www.americanbankingnews.com - May 18 at 10:17 PM
Tabula Rasa HealthCare (TRHC) Given New $68.00 Price Target at Chardan CapitalTabula Rasa HealthCare (TRHC) Given New $68.00 Price Target at Chardan Capital
www.americanbankingnews.com - May 18 at 3:53 PM
Tabula Rasa HealthCare (TRHC) Director Sells $1,594,307.96 in StockTabula Rasa HealthCare (TRHC) Director Sells $1,594,307.96 in Stock
www.americanbankingnews.com - May 17 at 7:36 PM
Tabula Rasa HealthCare (TRHC) Director Sells $3,242,636.31 in StockTabula Rasa HealthCare (TRHC) Director Sells $3,242,636.31 in Stock
www.americanbankingnews.com - May 15 at 7:16 PM
Tabula Rasa HealthCare (TRHC) Rating Increased to Buy at Zacks Investment ResearchTabula Rasa HealthCare (TRHC) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - May 15 at 3:09 PM
Zacks: Brokerages Anticipate Tabula Rasa HealthCare (TRHC) Will Post Quarterly Sales of $46.75 MillionZacks: Brokerages Anticipate Tabula Rasa HealthCare (TRHC) Will Post Quarterly Sales of $46.75 Million
www.americanbankingnews.com - May 14 at 4:59 AM
Tabula Rasa HealthCare (TRHC) Expected to Earn Q2 2018 Earnings of $0.01 Per ShareTabula Rasa HealthCare (TRHC) Expected to Earn Q2 2018 Earnings of $0.01 Per Share
www.americanbankingnews.com - May 14 at 1:21 AM
Brokers Offer Predictions for Tabula Rasa HealthCares Q2 2018 Earnings (TRHC)Brokers Offer Predictions for Tabula Rasa HealthCare's Q2 2018 Earnings (TRHC)
www.americanbankingnews.com - May 14 at 1:21 AM
$0.14 EPS Expected for Tabula Rasa HealthCare (TRHC) This Quarter$0.14 EPS Expected for Tabula Rasa HealthCare (TRHC) This Quarter
www.americanbankingnews.com - May 12 at 1:10 AM
Orsula V. Knowlton Sells 8,000 Shares of Tabula Rasa HealthCare (TRHC) StockOrsula V. Knowlton Sells 8,000 Shares of Tabula Rasa HealthCare (TRHC) Stock
www.americanbankingnews.com - May 9 at 7:53 PM
Tabula Rasa HealthCare (TRHC) Stock Rating Reaffirmed by Piper JaffrayTabula Rasa HealthCare (TRHC) Stock Rating Reaffirmed by Piper Jaffray
www.americanbankingnews.com - May 9 at 2:14 PM
Tabula Rasa HealthCare (TRHC) Given Buy Rating at CitigroupTabula Rasa HealthCare (TRHC) Given Buy Rating at Citigroup
www.americanbankingnews.com - May 9 at 1:29 PM
BRIEF-Tabula Rasa Healthcare Q1 Adjusted Non-GAAP Earnings Per Share $0.10BRIEF-Tabula Rasa Healthcare Q1 Adjusted Non-GAAP Earnings Per Share $0.10
www.reuters.com - May 9 at 9:22 AM
Tabula Rasa HealthCares (TRHC) CEO Calvin Knowlton on Q1 2018 Results - Earnings Call TranscriptTabula Rasa HealthCare's (TRHC) CEO Calvin Knowlton on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 9:22 AM
Tabula Rasa Healthcare: 1Q Earnings SnapshotTabula Rasa Healthcare: 1Q Earnings Snapshot
finance.yahoo.com - May 9 at 9:22 AM
Tabula Rasa HealthCare Releases Research Results Re: Pharmacist-Led Pharmacogenomics (PGx) Services for PACETabula Rasa HealthCare Releases Research Results Re: Pharmacist-Led Pharmacogenomics (PGx) Services for PACE
finance.yahoo.com - May 9 at 9:22 AM
Tabula Rasa HealthCare (TRHC) Issues  Earnings Results, Beats Expectations By $0.17 EPSTabula Rasa HealthCare (TRHC) Issues Earnings Results, Beats Expectations By $0.17 EPS
www.americanbankingnews.com - May 8 at 5:24 PM
Tabula Rasa HealthCare Announces First Quarter 2018 Operating ResultsTabula Rasa HealthCare Announces First Quarter 2018 Operating Results
finance.yahoo.com - May 8 at 4:36 PM
Tabula Rasa HealthCare (TRHC) Receives Consensus Recommendation of "Buy" from AnalystsTabula Rasa HealthCare (TRHC) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 6 at 8:01 PM
Peak PACE Solutions to Join Capstone Performance SystemsPeak PACE Solutions to Join Capstone Performance Systems
feeds.benzinga.com - May 3 at 1:38 PM
Tabula Rasa HealthCare (TRHC) Upgraded to "Buy" by ValuEngineTabula Rasa HealthCare (TRHC) Upgraded to "Buy" by ValuEngine
www.americanbankingnews.com - May 2 at 3:48 PM
Tabula Rasa HealthCare (TRHC) Scheduled to Post Earnings on TuesdayTabula Rasa HealthCare (TRHC) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - May 1 at 10:46 AM
Tabula Rasa HealthCare Subsidiary CareKinesis Signs Agreement with SpiriTrust Lutheran LIFETabula Rasa HealthCare Subsidiary CareKinesis Signs Agreement with SpiriTrust Lutheran LIFE
finance.yahoo.com - April 30 at 9:29 AM
$42.50 Million in Sales Expected for Tabula Rasa HealthCare (TRHC) This Quarter$42.50 Million in Sales Expected for Tabula Rasa HealthCare (TRHC) This Quarter
www.americanbankingnews.com - April 26 at 2:36 AM
$0.02 Earnings Per Share Expected for Tabula Rasa HealthCare (TRHC) This Quarter$0.02 Earnings Per Share Expected for Tabula Rasa HealthCare (TRHC) This Quarter
www.americanbankingnews.com - April 24 at 3:10 PM
Tabula Rasa HealthCare (TRHC) Upgraded to Strong-Buy at BidaskClubTabula Rasa HealthCare (TRHC) Upgraded to Strong-Buy at BidaskClub
www.americanbankingnews.com - April 24 at 9:58 AM
Tabula Rasa HealthCare Launches its Optimized Opioid Solution™ to Predict and Prevent Unintentional Opioid AbuseTabula Rasa HealthCare Launches its Optimized Opioid Solution™ to Predict and Prevent Unintentional Opioid Abuse
finance.yahoo.com - April 24 at 9:17 AM
Tabula Rasa Healthcare to Announce First Quarter 2018 Operating Results and Host Conference Call onTabula Rasa Healthcare to Announce First Quarter 2018 Operating Results and Host Conference Call on
www.nasdaq.com - April 23 at 4:31 PM
Tabula Rasa Healthcare to Announce First Quarter 2018 Operating Results and Host Conference Call on Tuesday, May 8, 2018Tabula Rasa Healthcare to Announce First Quarter 2018 Operating Results and Host Conference Call on Tuesday, May 8, 2018
finance.yahoo.com - April 23 at 4:31 PM
Tabula Rasa Healthcares SinfoníaRx Publishes Annual Performance ReportTabula Rasa Healthcare's SinfoníaRx Publishes Annual Performance Report
globenewswire.com - April 23 at 9:03 AM
Tabula Rasa Healthcare’s SinfoníaRx Publishes Annual Performance ReportTabula Rasa Healthcare’s SinfoníaRx Publishes Annual Performance Report
finance.yahoo.com - April 23 at 9:03 AM
Tabula Rasa HealthCare (TRHC) Receives New Coverage from Analysts at Chardan CapitalTabula Rasa HealthCare (TRHC) Receives New Coverage from Analysts at Chardan Capital
www.americanbankingnews.com - April 19 at 7:29 PM
Tabula Rasa HealthCare Subsidiary CareKinesis is Exclusive Provider of In-Home Medication Reminder Device for PACE OrganizationsTabula Rasa HealthCare Subsidiary CareKinesis is Exclusive Provider of In-Home Medication Reminder Device for PACE Organizations
finance.yahoo.com - April 16 at 9:12 AM
Tabula Rasa HealthCare Inc (TRHC) Short Interest UpdateTabula Rasa HealthCare Inc (TRHC) Short Interest Update
www.americanbankingnews.com - April 14 at 2:27 AM
Tabula Rasa HealthCare (TRHC) Price Target Raised to $18.00 at Robert W. BairdTabula Rasa HealthCare (TRHC) Price Target Raised to $18.00 at Robert W. Baird
www.americanbankingnews.com - April 12 at 8:29 PM
Tabula Rasa HealthCare Inc (TRHC) Receives Average Rating of "Buy" from BrokeragesTabula Rasa HealthCare Inc (TRHC) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - April 11 at 7:35 PM
Tabula Rasa HealthCare Inc (TRHC) CEO Sells $309,520.00 in StockTabula Rasa HealthCare Inc (TRHC) CEO Sells $309,520.00 in Stock
www.americanbankingnews.com - April 10 at 7:13 PM
 Brokerages Expect Tabula Rasa HealthCare Inc (TRHC) Will Post Quarterly Sales of $42.50 Million Brokerages Expect Tabula Rasa HealthCare Inc (TRHC) Will Post Quarterly Sales of $42.50 Million
www.americanbankingnews.com - April 9 at 2:34 AM
Zacks: Brokerages Expect Tabula Rasa HealthCare Inc (TRHC) to Post $0.02 Earnings Per ShareZacks: Brokerages Expect Tabula Rasa HealthCare Inc (TRHC) to Post $0.02 Earnings Per Share
www.americanbankingnews.com - April 7 at 5:22 PM
Tabula Rasa HealthCare (TRHC) Says CMS Changes to Medicare Part D Provide Potential Expansion of its Medication Therapy Management ServicesTabula Rasa HealthCare (TRHC) Says CMS Changes to Medicare Part D Provide Potential Expansion of its Medication Therapy Management Services
www.streetinsider.com - April 5 at 4:32 PM
CMS Changes to Medicare Part D Provide Potential Expansion of TRHC Medication Therapy Management Services for Medicare Advantage PlansCMS Changes to Medicare Part D Provide Potential Expansion of TRHC Medication Therapy Management Services for Medicare Advantage Plans
finance.yahoo.com - April 4 at 4:56 PM
Philadelphia Media Network Ranks Tabula Rasa HealthCare No. 6 on 2018 Top Places to WorkPhiladelphia Media Network Ranks Tabula Rasa HealthCare No. 6 on 2018 Top Places to Work
finance.yahoo.com - April 3 at 4:36 PM
Tabula Rasa HealthCare (TRHC) Research Coverage Started at CitigroupTabula Rasa HealthCare (TRHC) Research Coverage Started at Citigroup
www.americanbankingnews.com - March 30 at 4:32 PM
$42.50 Million in Sales Expected for Tabula Rasa HealthCare Inc (TRHC) This Quarter$42.50 Million in Sales Expected for Tabula Rasa HealthCare Inc (TRHC) This Quarter
www.americanbankingnews.com - March 23 at 3:06 AM
Tabula Rasa HealthCare Inc (TRHC) Director Sells $465,014.34 in StockTabula Rasa HealthCare Inc (TRHC) Director Sells $465,014.34 in Stock
www.americanbankingnews.com - March 22 at 10:20 PM
Tabula Rasa HealthCare (TRHC) Upgraded by BidaskClub to BuyTabula Rasa HealthCare (TRHC) Upgraded by BidaskClub to Buy
www.americanbankingnews.com - March 22 at 9:48 AM

SEC Filings

Tabula Rasa HealthCare (NASDAQ:TRHC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Tabula Rasa HealthCare (NASDAQ:TRHC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Tabula Rasa HealthCare (NASDAQ TRHC) Stock Chart for Saturday, May, 26, 2018

Loading chart…

This page was last updated on 5/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.